Global: All items in all

613 results

 | 1 Global

TMC125 Expanded access programme

Early access of TMC125 in combination with other antiretrovirals in treatment-experienced HIV-1 infected subjects with limited treatment options (TMC125-C214) This...

Timing of initiation of HCV therapy

Report Table of Contents Introduction Epidemiology HIV Management in Co-infection HCV Management in Co-infection HCV Therapy in Co-infection Adverse Events and...

The Value of Investing in HIV Research

CAHR, CANFAR, CIHR and CTN are proud to celebrate the signicant achievements made in Canadian HIV/AIDS research over the past 30 years and look forward to the discoveries to come.

The CTN Marks 25 Years of Excellence

The CTN will mark its 25th anniversary with a satellite symposium on July 21 at the 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) in Vancouver.